175 related articles for article (PubMed ID: 34079683)
41. Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population.
AlMarzoug A; AlOrainy M; AlTawil L; AlHayaza G; AlAnazi R; AlIssa A; AlSheikh A; AlKhalifah A; AlHarithy R
Int J Dermatol; 2022 Jul; 61(7):886-894. PubMed ID: 34716573
[TBL] [Abstract][Full Text] [Related]
42. Severe subtype of alopecia areata is highly associated with thyroid autoimmunity.
Bin Saif GA
Saudi Med J; 2016 Jun; 37(6):656-61. PubMed ID: 27279512
[TBL] [Abstract][Full Text] [Related]
43. Determination of Serum 25-Hydroxyvitamin D Levels in Patients with Alopecia Areata.
Singh Basukala M; Jha A; Dawadi R; Shrestha R
J Nepal Health Res Counc; 2023 Mar; 20(3):746-749. PubMed ID: 36974868
[TBL] [Abstract][Full Text] [Related]
44. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
Lee S; Kim BJ; Lee YB; Lee WS
JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
[TBL] [Abstract][Full Text] [Related]
45. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.
Lee HH; Gwillim E; Patel KR; Hua T; Rastogi S; Ibler E; Silverberg JI
J Am Acad Dermatol; 2020 Mar; 82(3):675-682. PubMed ID: 31437543
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-1 receptor antagonist allele 2 and familial alopecia areata.
Barahmani N; de Andrade M; Slusser J; Zhang Q; Duvic M
J Invest Dermatol; 2002 Feb; 118(2):335-7. PubMed ID: 11841553
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study.
Narang T; Daroach M; Kumaran MS
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133875
[TBL] [Abstract][Full Text] [Related]
48. Serum Zinc Concentration in Patients with Alopecia Areata.
Lalosevic J; Gajic-Veljic M; Lalosevic Misovic J; Nikolic M
Acta Derm Venereol; 2023 Oct; 103():adv13358. PubMed ID: 37787421
[TBL] [Abstract][Full Text] [Related]
49. Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy.
Oba MC; Askin O; Balci Ekmekci O; Serdaroglu S
J Cosmet Dermatol; 2021 Mar; 20(3):971-975. PubMed ID: 32808476
[TBL] [Abstract][Full Text] [Related]
50. Biomarkers in alopecia Areata: A systematic review and meta-analysis.
Zaaroura H; Gilding AJ; Sibbald C
Autoimmun Rev; 2023 Jul; 22(7):103339. PubMed ID: 37087083
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of Serum Homocysteine, High-Sensitivity CRP, and RBC Folate in Patients with Alopecia Areata.
Yousefi M; Namazi MR; Rahimi H; Younespour S; Ehsani AH; Shakoei S
Indian J Dermatol; 2014 Nov; 59(6):630. PubMed ID: 25484412
[TBL] [Abstract][Full Text] [Related]
52. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity.
Bain KA; McDonald E; Moffat F; Tutino M; Castelino M; Barton A; Cavanagh J; Ijaz UZ; Siebert S; McInnes IB; Astrand A; Holmes S; Milling SWF
Br J Dermatol; 2020 Jan; 182(1):130-137. PubMed ID: 30980732
[TBL] [Abstract][Full Text] [Related]
53. Association of Alopecia Areata With Attention-Deficit/Hyperactivity Disorder Stimulant Medication: A Case-Control Study.
Meaux TA; McMahon PM; Jones GN; Bush AE; Kennedy JJ; Poche GW
Ochsner J; 2021; 21(2):139-142. PubMed ID: 34239372
[No Abstract] [Full Text] [Related]
54. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis.
Colombe BW; Lou CD; Price VH
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):216-9. PubMed ID: 10674369
[TBL] [Abstract][Full Text] [Related]
55. The Role of Micronutrients in Alopecia Areata: A Review.
Thompson JM; Mirza MA; Park MK; Qureshi AA; Cho E
Am J Clin Dermatol; 2017 Oct; 18(5):663-679. PubMed ID: 28508256
[TBL] [Abstract][Full Text] [Related]
56. Combined Diet and Supplementation Therapy Resolves Alopecia Areata in a Paediatric Patient: A Case Study.
Harvey CJ
Cureus; 2020 Nov; 12(11):e11371. PubMed ID: 33304703
[TBL] [Abstract][Full Text] [Related]
57. Impact of Vitamin D Status on Cardiometabolic Complications among Children and Adolescents with Type 1 Diabetes Mellitus.
Al Shaikh A; Al Zahrani AM
J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):48-54. PubMed ID: 26757741
[TBL] [Abstract][Full Text] [Related]
58. Intralesional vitamin D3 in treatment of alopecia areata: A randomized controlled clinical trial.
Rashad AF; Elgamal E; Fouda I
J Cosmet Dermatol; 2022 Oct; 21(10):4617-4622. PubMed ID: 35152536
[TBL] [Abstract][Full Text] [Related]
59. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
Mostaghimi A; Gao W; Ray M; Bartolome L; Wang T; Carley C; Done N; Swallow E
JAMA Dermatol; 2023 Apr; 159(4):411-418. PubMed ID: 36857069
[TBL] [Abstract][Full Text] [Related]
60. Vitamin D Deficiency in Alopecia Areata.
Ghafoor R; Anwar MI
J Coll Physicians Surg Pak; 2017 Apr; 27(4):200-202. PubMed ID: 28492146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
